Minneapolis Clinical Trials

2105 Study Part B

Participate in a clinical study of a potential new cancer treatment

4 nights
1 visits

This is a potential treatment for several cancers (including breast & ovarian cancer) that has already gone through clinical trials with patients. In this study we will compare how different formulations of the medication are metabolized. This investigational product inhibits specific proteins that play a role in the growth of cancer cells. It is not a form of chemo- or radiotherapy.

There is a 4 day & night consecutive stay in-house at our St. Paul facility plus 1 follow-up visit & 1 follow-up phone call

Reimbursement for study participation will be provided for time and travel of up to $1,750. This study has been approved by an independent ethics committee

Call Gigi at 651-724-7832 or register your interest to discuss your eligibility today!


Eligibility

Biological Sex Healthy males or females
Age 18 - 55 years old
BMI 18.5 - 30
Medications Able to avoid taking any medications 2 weeks prior to first drug administration
Smoking History No smoking for at least 1 month prior to admission